Edition:
United Kingdom

Yasmeen Abutaleb

U.S. FDA chief tough on e-cigarettes steps down abruptly

06 Mar 2019

WASHINGTON U.S. Food and Drug Administration Commissioner Scott Gottlieb said on Tuesday that he plans to step down next month, a sudden resignation that calls into question how the agency will handle issues such as surging e-cigarette use among teens and efforts to increase competition in prescription drugs.

CORRECTED-UPDATE 4-U.S. FDA chief tough on e-cigs steps down in surprise resignation

06 Mar 2019

WASHINGTON, March 5 U.S. Food and Drug Administration Commissioner Scott Gottlieb said on Tuesday that he plans to step down next month, a sudden resignation that calls into question how the agency will handle issues such as surging e-cigarette use among teens and efforts to increase competition in prescription drugs.

U.S. Senator Sanders urges FDA to allow older versions of $375,000 drug

28 Feb 2019

U.S. Senator Bernie Sanders this week urged regulators to allow pharmacies and manufacturers to resume distributing unbranded, lower-cost versions of a drug used to treat a rare neuromuscular disorder, according to a letter provided by his office to Reuters.

U.S. House Democrats introduce sweeping 'Medicare for All' bill

28 Feb 2019

WASHINGTON Democrats in the U.S. House of Representatives unveiled an ambitious proposal on Tuesday to move all Americans into the government's Medicare health insurance program, tapping into public frustration over the rising cost of healthcare that has become a key issue for the party as it seeks to gain control of Congress and the White House in 2020. | Video

U.S. Senator Sanders urges FDA to allow older versions of $375K drug

28 Feb 2019

Feb 28 U.S. Senator Bernie Sanders this week urged regulators to allow pharmacies and manufacturers to resume distributing unbranded, lower-cost versions of a drug used to treat a rare neuromuscular disorder, according to a letter provided by his office to Reuters.

U.S. senators tell drug company executives pricing is 'morally repugnant'

26 Feb 2019

WASHINGTON/NEW YORK U.S. senators called drug pricing practices "morally repugnant" and told drug company executives they do not want to hear them blame others for the high prices, taking an aggressive stance at a Senate hearing on the rising costs of prescription medicines.

Drug company executives to testify before U.S. Senate

26 Feb 2019

WASHINGTON/NEW YORK Seven drug company executives will testify about rising prescription drug prices before a powerful U.S. Senate Committee on Tuesday, marking a sharp escalation in lawmakers' promises to address high medicine costs.

UPDATE 2-U.S. Senators launch bipartisan probe into rising insulin prices

22 Feb 2019

WASHINGTON, Feb 22 Two top U.S. senators launched an investigation into rising insulin prices on Friday, sending letters to the three leading manufacturers seeking answers as to why the nearly 100-year-old drug's cost has rapidly risen, causing taxpayers to spend millions of dollars a year.

World News